Tokyo, June 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062039) titled 'Development of Beam Imaging Technology for Scanning Irradiation in Heavy Ion Radiotherapy' on June 24.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - National Institutes for Quantum Science and Technology (QST)
Condition:
Condition - Choroidal malignant melanoma.
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - During heavy ion beam irradiation of a patient, secondary electron bremsstrahlung emitted from within the patient is measured two-dimensionally using a newly developed SEB imaging device by QST (Takasaki Advanced Radiation Research Institute). This enables visualization of the beam's range within the body. By performing time-resolved measurements during scanning irradiation, changes in the beam's arrival position can be monitored.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients aged 18 years or older with choroidal malignant melanoma who are scheduled to undergo heavy ion radiotherapy, and from whom informed consent has been obtained.
Key exclusion criteria - Individuals deemed unsuitable for participation in this study by the principal investigator or other responsible physicians due to medical or other reasons.
Target Size - 5
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 06 Month 11 Day
Date of IRB - 2026 Year 06 Month 16 Day
Anticipated trial start date - 2026 Year 06 Month 24 Day
Last follow-up date - 2029 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070988
Disclaimer: Curated by HT Syndication.
